Fig. 2From: Increased neutrophil–lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classificationRecurrence-free-survival and overall survival for PanNENs stratified by NLR. A higher NLR showed a significant correlation with shorter RFS (median RFS duration, 117.8 months, P < 0.001) (a) and poor OS (median OS duration, 95.2 months, P = 0.032) after curative resection (b)Back to article page